First, current studies have extensively examined AChR+ MG cases, leaving a scarcity of knowledge for the less common, but equally debilitating, MuSK+, LRP4+, and seronegative phenotypes of MG — although the nature of a small subpopulation of a rare disease makes such studies challenging. This evidence concerns the gene LRP4 and myasthenia gravis.